Stenhouse Mark Insider Trades

Insider Trading History

Track insider trading activity for Stenhouse Mark. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
Director
Holding Value $546k 54,122 shares
Last Trade
May 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$275k 24,122 shares
$11.40
$10.09
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
Director
Holding Value $303k 30,000 shares
Last Trade
Jun 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$86.6k 17,500 shares
$4.95
$10.09
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
Director
Holding Value $177k 17,500 shares
Last Trade
May 23, 2024 Sale (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$180k 17,500 shares
$10.30
$10.09
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
Director
Holding Value $197k 19,500 shares
Last Trade
May 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$108k 10,500 shares
$10.30
$10.09
Prometheus Biosciences
Prometheus Biosciences RXDX
Chief Operating Officer
Holding Value $0 0 shares
Last Trade
Jun 16, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$97M 485,038 shares
$199.92
$199.92
Prometheus Biosciences
Prometheus Biosciences RXDX
Chief Operating Officer
Holding Value $2.54M 12,708 shares
Last Trade
Jun 01, 2023 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$2.78M 14,000 shares
$198.65
$199.92
Prometheus Biosciences
Prometheus Biosciences RXDX
Chief Operating Officer
Holding Value $2.8M 14,000 shares
Last Trade
Jun 01, 2023 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$2.78M 14,000 shares
$198.65
$199.92
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
Director
Holding Value $151k 15,000 shares
Last Trade
May 25, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$176k 15,000 shares
$11.72
$10.09
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
Director
Holding Value $151k 15,000 shares
Last Trade
May 25, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$111k 15,000 shares
$7.40
$10.09
Prometheus Biosciences
Prometheus Biosciences RXDX
Chief Operating Officer
Holding Value $17.3M 86,582 shares
Last Trade
May 20, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.56M 86,582 shares
$29.56
$199.92
Prometheus Biosciences
Prometheus Biosciences RXDX
Chief Operating Officer
Holding Value $14.1M 70,371 shares
Last Trade
Nov 14, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.56M 70,371 shares
$36.32
$199.92
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
Director
Holding Value $126k 12,500 shares
Last Trade
May 21, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$444k 12,500 shares
$35.49
$10.09
Prometheus Biosciences
Prometheus Biosciences RXDX
Chief Operating Officer
Holding Value $2.8M 14,000 shares
Last Trade
Mar 16, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$322k 14,000 shares
$23.00
$199.92
Prometheus Biosciences
Prometheus Biosciences RXDX
Chief Operating Officer
Holding Value $0 0 shares
Last Trade
Mar 11, 2021 Sale
No data
No data
$199.92
Prometheus Biosciences
Prometheus Biosciences RXDX
Chief Operating Officer
Holding Value $0 0 shares
Last Trade
Feb 04, 2021 Sale
No data
No data
$199.92
Exact Sciences
Exact Sciences EXAS
President, Cologuard
Holding Value $3.1M 29,571 shares
Last Trade
Apr 03, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$677k 11,948 shares
$56.69
$104.91
Exact Sciences
Exact Sciences EXAS
President, Cologuard
Holding Value $4.36M 41,519 shares
Last Trade
Apr 02, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.44M 25,000 shares
$57.60
$104.91
Exact Sciences
Exact Sciences EXAS
President, Cologuard
Holding Value $2.62M 25,000 shares
Last Trade
Apr 02, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.44M 25,000 shares
$57.60
$104.91
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
Director
Holding Value $202k 20,000 shares
Last Trade
Mar 17, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$597k 20,000 shares
$29.84
$10.09
Exact Sciences
Exact Sciences EXAS
President, Cologuard
Holding Value $1.73M 16,519 shares
Last Trade
Feb 27, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$84.4k 1,051 shares
$80.27
$104.91

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up